STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] Invivyd, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Point72 group disclosed a passive 13G stake in Invivyd, Inc. The filing shows Point72 Asset Management, Point72 Capital Advisors and Steven A. Cohen beneficially own 16,730,467 shares, representing 8.0% of Invivyd's outstanding common stock based on 209,377,291 shares outstanding following the issuer's August 22, 2025 underwritten offering. The reported shares are held through Point72 Associates, LLC, with shared voting and dispositive power and no sole voting or dispositive power reported. The filing is submitted on a joint basis and states the position is not intended to influence control of the issuer.

Positive
  • Material institutional interest disclosed: Point72 group reports an 8.0% stake, which is a clear sign of significant investor interest.
  • Passive intent stated: Filing is on Schedule 13G and includes a certification that the shares were not acquired to change or influence control, reducing immediate governance uncertainty.
Negative
  • None.

Insights

TL;DR: Point72 reports an 8.0% passive stake in Invivyd, disclosed via a joint Schedule 13G.

Point72 affiliates and Steven A. Cohen report beneficial ownership of 16,730,467 shares, equal to 8.0% of the company based on the post-offering share count provided in the filing. The ownership is reported as shared voting and dispositive power with no sole control, and the filing expressly characterizes the stake as not intended to change or influence control. For investors, a disclosed >5% passive stake from a large asset manager is material because it signals institutional interest without an active control intent.

TL;DR: Joint 13G shows coordinated reporting by related Point72 entities and Mr. Cohen, indicating common control but passive intent.

The Schedule 13G is filed jointly by Point72 Asset Management, Point72 Capital Advisors and Steven A. Cohen, and includes a Joint Filing Agreement (Exhibit 99.1). The cover-page details report 0 sole voting/dispositive power and 16,730,467 shared voting/dispositive power, consistent with collective advisory control over fund holdings rather than direct personal ownership. The certification confirms the shares were not acquired to influence control, which is the key distinction between a 13G and a 13D filing.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/27/2025
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/27/2025
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/27/2025
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

FAQ

How many Invivyd (IVVD) shares does Point72 report owning?

Point72 Asset Management, Point72 Capital Advisors and Steven A. Cohen report beneficial ownership of 16,730,467 shares of Invivyd common stock.

What percentage of Invivyd does the 13G filing report?

The filing reports ownership equal to 8.0% of the outstanding shares, based on 209,377,291 shares outstanding after the August 22, 2025 offering.

Is Point72 seeking to influence control of Invivyd according to the filing?

No. The Schedule 13G includes a certification that the securities were not acquired and are not held to change or influence control of the issuer.

Through what vehicle are the shares held?

The shares are held by Point72 Associates, LLC, an investment fund managed by Point72 Asset Management, with Cubist Systematic Strategies, LLC and Point72 Asia (Singapore) Pte. Ltd. acting as sub-advisors for portions of the shares.

Who signed the Schedule 13G on behalf of Point72?

The filing is signed by Jason M. Colombo as Authorized Person for Point72 Asset Management and Point72 Capital Advisors, and on behalf of Steven A. Cohen, dated August 27, 2025.
Invivyd

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Latest SEC Filings

IVVD Stock Data

664.96M
201.17M
19.2%
60.75%
2.52%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW HAVEN